As of 8:10 PM 05/23/13 All times are local (Market data is delayed by at least 15 minutes).
Executive Profile*
Wayne T. Hockmeyer Ph.D.Lead Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee, GenVec, Inc. | |
| Age | Total Calculated Compensation | This person is connected to 85 board members in 8 different organizations across 16 different industries.
See Board Relationships |
| 67 | $107,318
|
Background*
Dr. Wayne T. Hockmeyer, Ph.D., served as the President of MedImmune Ventures Inc., a wholly-owned subsidiary of MedImmune Inc. from 2002 to June 1, 2007. Dr. Hockmeyer founded MedImmune, Inc. in April 1988 and served as its President and Chief Executive Officer from April 1988 to October 2000. From 1986 to 1988, he served as Vice President of Research and Development for Praxis Biologics Inc. He has been Chairman of Board of TolerRx Inc. since March 2005. Dr. Hockmeyer ... served as the Chairman of the Board of MedImmune Inc. from May 1993 to June 1, 2007 and served as Chairman of its subsidiary, MedImmune Ventures Inc. He has been its Lead Independent Director since April 2004. He serves as a Director of Cellective Therapeutics, Inc. He has been Director of TolerRx Inc. since April 2001. He serves as Director of Altiris Therapeutics, Inc. He has been a Director of Idenix Pharmaceuticals Inc., since February 2002. Dr. Hockmeyer has been Director of GenVec Inc. since December 2000 and serves as its Lead Independent Director. He has been Director of MedImmune Vaccines, Inc. (formerly Aviron) since March 2000. He has been a Director of Baxter International Inc. since September 2007. He serves as a Director of Kémia, Inc. and Advanced Pharma, Inc. Dr. Hockmeyer serves as a Member of the board of Directors of the Biotechnology Industry Organization. He serves as Member of Maryland Technology Development Corporation. He served as a Director of Rib-x Pharmaceuticals, Inc. since June 21, 2006. He served as a Director of MiddleBrook Pharmaceuticals, Inc. (Formerly Advancis Pharmaceutical Corp.) from January 1, 2000 to June 23, 2009 and Lead Independent Director from May 2004 to June 23, 2009. He served as a Director of Sequoia Pharmaceuticals, Inc. He served as a Director of InterMune Inc. since February 2000. He served as a Director of MedImmune Inc. from May 1988 to June 1, 2007. He served as a Director of Vanda Pharmaceuticals, Inc. from 2004 to September 07, 2006. He served as a Director of Tercica Inc. from July 2003 to April 19, 2005. He served as a Director of Kémia, Inc. since August 2006. He served as a Director of Verenium Corporation (Formerly Diversa Corp.) from August 2001 to May 12, 2004. From 1980 to 1986, he served as Chairman of the Department of Immunology at the Walter Reed Army Institute of Research and from 1966 to 1986, he served as a commissioned officer in the U.S. Army. He serves as Member of Maryland Economic Development Commission. Dr. Hockmeyer serves as a Member of the Technology Council of Maryland, a Member of the board of visitors of the University of Maryland Biotechnology Institute and the University of Maryland Baltimore County, and a Member of the board of trustees of the University of Maryland College Park Foundation. He is a member of the Governor's Workforce Investment Board (GWIB). He also serves as member of the Governor's Scientific Advisory Board and serves on the boards of a number of publicly traded biotechnology companies as well as several educational and philanthropic organizations. He serves as member of the Board of Governors of The Chesapeake Bay Maritime Museum. Dr. Hockmeyer has authored more than 70 papers and articles in the immunology and vaccine development fields. He is a Paul A. Siple Medal winner. He was recognized internationally for his research on malaria vaccines. His achievements in business were recognized in 1993 when he was selected as the “Ernst & Young Greater Washington Entrepreneur of the Year“. He was also a 2003 inductee to the Maryland Business Hall of Fame and was named Washington Business Leader of the Year 2003 by The Washingtonian Magazine, July 2003. He is the 2004 Chief Executive Officer of the Year for The George Washington University School of Business. Dr. Hockmeyer was recognized, in 1998, by the University of Florida as a Distinguished Alumnus and in 2002. In 2002, he was awarded a Doctor Science honoris from Purdue University. Dr. Hockmeyer earned his BS from Purdue University in 1966 and his PhD from the University of Florida in 1972.
Corporate Headquarters*
65 West Watkins Mill Road
Gaithersburg, Maryland 20878
United States
Phone: 240-632-0740
Fax: 240-632-0735
Board Members Memberships*
Director Former Director Director 1988-2007 Founder 2000-Present Director 2000-Present Lead Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee 2000-N/A Former Director 2000-2009 Former Lead Independent Director, Chairman of Compensation Committee and Member of Executive Committee 2001-2004 Former Director 2001-Present Chairman, Member of Audit Committee, Member of Nominating Committee and Member of Corporate Governance Committee 2002-Present Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee 2003-2005 Former Director, Member of Audit Committee and Member of Compensation Committee 2004-2006 Former Director 2006-N/A Former Director 2006-Present Director 2007-Present Director, Chairman of Science & Technology Committee and Member of Finance Committee
Education*
Honorary Doctorate Purdue University Doctorate Purdue University ScD Purdue University Bachelor's Degree Purdue University BS Purdue University PhD University of Florida
Other Affiliations*
|
Annual Compensation*
There is no Annual Compensation data available.
Stock Options*
| Exercisable Options | 13,500 | | Unexercisable Options | 15,000 | | Total Number of Options | 28,500 |
Total Compensation*
| Total Annual Cash Compensation | $78,000 | | Total Calculated Compensation | $107,318 |
|
*Data is at least as current as the most recent Definitive Proxy.
Stock Quotes
Market data is delayed at least 15 minutes.
| Recently Viewed |
|
GNVC:US
|
$0.70 USD |
0.00 |
 |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Sponsored Financial Commentaries
Sponsored Links
